EcoR1 Capital Fund Qualified, L.P. is 10% Owner at Kura Oncology, Inc. (KURA). They have made 9 open-market trades across 4 companies since 2017, most recently 2023-09-21.
CIK 0001598292
6 open-market purchases totalling $26.3M since 2017, against 3 sales. Across 6 scored buys the stock is down 3.2% at ninety days, and 10.2 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 33% | 50% | 50% |
| Avg Move | -2.6% | +1.9% | -3.2% |
| Alpha | -1.1% | +2.0% | -10.2% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NUVB | BUY | 2023-09-19 | 2023-09-22 | $1.26 | $6.7M | -8.1% | -14.8% | +8.9% |
| NUVB | BUY | 2021-04-09 | 2021-04-13 | $9.89 | $9.1M | +0.6% | -1.8% | -17.5% |
| KURA | BUY | 2018-12-18 | 2019-01-10 | $13.57 | $5.8M | -8.5% | -14.2% | -5.9% |
| KURA | SELL | 2018-12-17 | 2019-01-10 | $13.20 | $350K | -8.5% | -14.2% | -5.9% |
| KURA | BUY | 2018-12-11 | 2018-12-13 | $13.90 | $1.1M | -0.7% | +18.9% | +13.8% |
| KURA | BUY | 2018-12-03 | 2018-12-06 | $13.50 | $3.2M | +1.6% | +15.4% | +0.4% |
| LIFE | SELL | 2018-05-14 | 2018-05-16 | $0.93 | $6.0M | -8.7% | +6.3% | -30.5% |
| ATYR | SELL | 2017-11-08 | 2017-12-14 | $4.08 | $56K | -0.3% | +7.8% | -19.1% |
| ATYR | BUY | 2017-10-01 | 2017-12-14 | $4.82 | $262K | -0.3% | +7.8% | -19.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.